Cargando…

A19 Genetic markers for protease inhibitor drug resistance in regions outside of the protease gene

Detalles Bibliográficos
Autores principales:	Giandhari, J., Gordon, M., van Vuuren, C., Moodley, P., de Oliveira, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstract Overview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565947/ https://www.ncbi.nlm.nih.gov/pubmed/28845261 http://dx.doi.org/10.1093/ve/vew036.018

Ejemplares similares

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria
por: James, Onyemata E., et al.
Publicado: (2017)

A18 HIV-1 genetic diversity and drug resistance in Haiti
por: Delva, G, et al.
Publicado: (2018)

A3 Brazilian network for HIV drug resistance surveillance: An investigation of pre-treatment drug resistance transmission chains
por: Véras, N M C, et al.
Publicado: (2018)

A67 Use of next-generation whole-genome sequencing to understand drug-resistant Mycobacterium tuberculosis in Botswana
por: Iketleng, T, et al.
Publicado: (2018)

A9 Deep sequencing analysis to investigate the importance of within host genetic diversity and evolution of influenza A viruses for the development of resistance against neuraminidase inhibitors
por: Roosenhoff, R., et al.
Publicado: (2017)

A52 MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity
por: Chu, D K W, et al.
Publicado: (2019)

A16 Next-generation sequencing to detect transmitted drug resistance mutations in Romanian people who inject drugs
por: Surleac, Marius, et al.
Publicado: (2019)

A12 Modeling residual HIV replication and the emergence of drug resistance on ART
por: Michael Bale, J, et al.
Publicado: (2019)

A1 Pairwise diversity and tMRCA as potential markers of HIV infection recency
por: Moyo, Sikhulile, et al.
Publicado: (2018)

A2 Phylogenetic investigation of transmitted HIV-1 drug resistance mutations in Denmark, 2009–17
por: Fonager, J, et al.
Publicado: (2019)

A40 Persistent circulation of highly divergent HIV-1M lineages in the Congo Basin Region
por: Tongo, M., et al.
Publicado: (2017)

A17 Transmitted drug-resistant mutations among recently infected HIV-1 patients in Israel, 2000–2014
por: Moscona, Roy, et al.
Publicado: (2018)

A16 Primary drug resistance among children infected with HIV-1 in Mozambique: Impact of maternal and neonatal prophylaxis
por: Ismael, Nália, et al.
Publicado: (2018)

A2 Optimization of the results generated by large-scale sequencing for the study of drug resistance in HIV infection: A systematic review
por: Fernández-Caballero, J A, et al.
Publicado: (2018)

A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)

A13 HIV drug resistance over a decade of antiretroviral therapy scale-up for HIV/AIDS patients in Vietnam
por: Nguyen, L.A., et al.
Publicado: (2017)

A41 Characterization of NS5 coding region resistance associated substitutions from DAA-naïve GT1 HCV-infected patients in a Portuguese cohort
por: Brandao, R, et al.
Publicado: (2018)

A4 Development of HIV drug resistance in HIV-infected patients failing second line regimen in Zimbabwe: A public health concern
por: Kouamou, V, et al.
Publicado: (2018)

A39 Genetic diversity of the hepatitis C virus NS5B gene during HIV/HCV co-infection
por: Blackard, Jason T
Publicado: (2018)

A66 Multi-drug-resistant Klebsiella pneumoniae strains circulating in hospital setting: Whole-genome sequencing and Bayesian phylogenetic analysis for outbreak investigations
por: Cella, E, et al.
Publicado: (2018)

A37 HIV drug resistance monitoring in children receiving first line antiretroviral therapy at two pediatric hospitals in Ho Chi Minh City
por: Luong, Anh Q., et al.
Publicado: (2017)

Bacterial cooperation in the wild and in the clinic: Are pathogen social behaviours relevant outside the laboratory?
por: Harrison, Freya
Publicado: (2013)

The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU)
por: KORABLIOVIENE, J., et al.
Publicado: (2018)

Genetic Mechanisms and Mental Retardation
por: Trembath, Richard C
Publicado: (1994)

Genetic Counselling and Testing in Europe
por: Harris, Rodney
Publicado: (1998)

A45 Genetic diversity of anelloviruses in the blood virome
por: Thijssen, Marijn, et al.
Publicado: (2019)

Dissecting Hypertension: The Role of the 'New Genetics'
por: Jamieson, Andrew
Publicado: (1994)

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
por: van der Gronde, Toon, et al.
Publicado: (2017)

Marine Biodiversity and Biogeography – Regional Comparisons of Global Issues, an Introduction
por: O'Dor, Ron, et al.
Publicado: (2010)

Effects of Methionine Supplementation on the Expression of Protein Deposition-Related Genes in Acute Heat Stress-Exposed Broilers
por: Del Vesco, Ana Paula, et al.
Publicado: (2015)

Integrating molecular networks with genetic variant interpretation for precision medicine
por: Capriotti, Emidio, et al.
Publicado: (2018)

A42 Genetic variability and phylogeography of hepatitis B virus genotype D in Brazil
por: Spitz, N, et al.
Publicado: (2018)

A2 HIV transmission networks among injection drug users in Pakistan
por: Cholette, Francois, et al.
Publicado: (2017)

A59 Expansion of genetic diversity and interspecies transmission dynamics of swine influenza viruses in China
por: Jin, Ziying, et al.
Publicado: (2018)

The Blood-Brain Barrier: Clinical Implications for Drug Delivery to the Brain
por: De Boer, A G, et al.
Publicado: (1994)

A29 Wolbachia for dengue control; will dengue viruses evolve resistance?
por: Vi, T.T., et al.
Publicado: (2017)

On the Discovery and Development of Pimavanserin: A Novel Drug Candidate for Parkinson’s Psychosis
por: Hacksell, Uli, et al.
Publicado: (2014)

A15 Archived ART resistance in the latent reservoir of virally suppressed Ugandans
por: Capoferri, A A, et al.
Publicado: (2019)

A3 Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo, Mozambique
por: Ismael, Nália, et al.
Publicado: (2017)

A46 Partial genetic characterization of a Brazilian strain of yellow fever virus from an epizootic outbreak in 2009
por: Mosimann, A L P, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8nknp5rlfo6e6kpo15p9alhl8n